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Biochemical oscillations are ubiquitous in living organisms. In an autonomous system, not influenced by an
external signal, they can only occur out of equilibrium. We show that they emerge through a generic nonequi-
librium phase transition, with a characteristic qualitative behavior at criticality. The control parameter is the
thermodynamic force, which must be above a certain threshold for the onset of biochemical oscillations. This
critical behavior is characterized by the thermodynamic flux associated with the thermodynamic force, its
diffusion coefficient, and the stationary distribution of the oscillating chemical species. We discuss metrics for
the precision of biochemical oscillations by comparing two observables, the Fano factor associated with the
thermodynamic flux and the number of coherent oscillations. Since the Fano factor can be small even when
there are no biochemical oscillations, we argue that the number of coherent oscillations is more appropriate
to quantify the precision of biochemical oscillations. Our results are obtained with three thermodynamically
consistent versions of known models: the Brusselator, the activator-inhibitor model, and a model for KaiC
oscillations.
I. INTRODUCTION
Living systems need biochemical oscillators1 for the
timing and control of several key processes such as cir-
cadian rhythms2,3 and the cell cycle4. Oscillations can
only set in if the system is out of equilibrium. The con-
trol parameter that has to be non-zero for the system to
be out of equilibrium is the thermodynamic force. For in-
stance, for a system in contact with a bath that contains
a fixed concentration of adenosine triphosphate (ATP),
the thermodynamic force is the free energy liberated with
the hydrolysis of one ATP molecule.
More specifically, in a recent study on the relation be-
tween energy dissipation and the precision of biochemical
oscillations, Cao et al.5 have shown that the thermody-
namic force must be above a certain threshold for the
onset of biochemical oscillations. Therefore, a natural
question that arises is whether biochemical oscillators
display a phase transition. In other words, what kind
of non-analytical behavior do physical observables dis-
play at this critical thermodynamic force? It is worth
noting that the relation between biochemical oscillations
and thermodynamics has also been studied in6–10.
In this paper, we show that a generic phase transition
takes place in biochemical oscillators. As in the well-
known theory of nonequilibrium phase transitions11–15,
this phase transition is associated with a Hopf bifur-
cation, i.e., the onset of limit cycle, in the determinis-
tic rate equations. An observable that characterizes the
transition is the steady state distribution of the chem-
ical species that oscillates. This distribution becomes
bimodal above the critical force. We analyze the crit-
ical behavior of the fluctuating thermodynamic current
conjugate to the thermodynamic force. The average of
this current is the rate at which the biochemical oscil-
lator consumes ATP. The first derivative of this average
with respect to the thermodynamic force is found to be
discontinuous at the critical point. We also investigate
fluctuations of this thermodynamic current. In particu-
lar, its diffusion coefficient is found to diverge there.
Since these biochemical oscillations can occur in sys-
tems with a finite number of molecules that lead to rela-
tively large fluctuations, it is natural to study the preci-
sion of biochemical oscillations5,16,17. More broadly, the
relation between precision and dissipation in biophysics
has been intensively investigated18–23. We analyze the
relation between the Fano factor associated with the ther-
modynamic current and the number of coherent oscilla-
tions. The Fano factor has been analyzed for theoret-
ical studies related to single molecule experiments24–28
and has been proposed as an observable that can quan-
tify the precision of biochemical oscillators17,29. Interest-
ingly, this Fano factor has a universal lower bound that
depends solely on the thermodynamic force, which fol-
lows from the thermodynamic uncertainty relation30–32.
The number of coherent oscillations, which is the num-
ber of periods for which different stochastic realizations
remain coherent with each other, is a standard measure of
the precision of biochemical oscillators5,16,33–38. It can be
used to identify the onset of biochemical oscillations, i.e.,
it is zero below the critical force and becomes non-zero
above it5. We show that the Fano factor does not prop-
erly quantify the precision of biochemical oscillations.
This observable that diverges at the critical point, due
to the divergence of the diffusion coefficient, is shown to
be small below the critical point, indicating high preci-
sion even if there are no biochemical oscillations.
We consider three different models for biochemical
oscillators: the Brusselator39, the activator-inhibitor
model5, and a model for the oscillations in the phospho-
rylation level of KaiC40, which is a protein related to the
regulation of the circadian rhythm of cyanobacteria41.
The paper is organized as follows. In Sec. II we in-
troduce the three models and analyze their critical be-
2havior. In Sec. III we discuss metrics for the precision
of biochemical oscillations, with the comparison between
the number of coherent oscillations and the Fano factor.
We conclude in Sec. IV. Details of the activator-inhibitor
model and the KaiC model are provided in Appendix A
and Appendix B, respectively.
II. PHASE TRANSITION
A. BRUSSELATOR
1. Model definition
The Brusselator is a paradigmatic model for biochem-
ical oscillations39,42–44. It consists of two intermediate
species X and Y in a volume Ω. The external bath
contains two chemical species A and B at fixed concen-
trations [A] and [B], respectively. The set of chemical
reactions is
A
k1−−⇀↽−
k
−1
X,
B
k2−−⇀↽−
k
−2
Y,
2X + Y
k3−⇀↽−
k3
3X,
(1)
where k1, k−1, k2, k−2, k3 are transition rates. For con-
venience we assume that the transition rates for the for-
ward and backward direction in the third reaction are
the same. The system is driven out of equilibrium due
to a difference of chemical potential between A and B,
which is written as∆µ ≡ µB−µA. For example, consider
the following cycle: a Y molecule is created with rate k2,
then a Y molecule is transformed into anX molecule with
rate k3 and, finally, an X molecule is degraded with rate
k−1. This cycle leads to the consumption of substrate B
and generation of product A. The thermodynamic force
associated with this cycle is
∆µ ≡ ln
k−1k2[B]
k−2k1[A]
, (2)
where the temperature T and Boltzmann’s constant kB
are set to kBT = 1 throughout this paper. The above re-
lation between the thermodynamic parameter ∆µ and
the transition rates is known as generalized detailed
balance45.
The state of the system is determined by two vari-
ables, the total number of X molecules nX and the to-
tal number of Y molecules nY . The time evolution of
P (nX , nY , t), the probability to find the system in state
(nX , nY ) at time t, is governed by the chemical master
equation, which reads
∂tP (nX , nY , t) =
{
Ωk1[A]
[
ǫ−X − 1
]
+Ωk2[B]
[
ǫ−Y − 1
]
+ k−1
[
(nX + 1)ǫ
+
X − nX
]
+ k−2
[
(nY + 1)ǫ
+
Y − nY
]
+
k3
Ω2
[
(nX − 1)(nX − 2)(nY + 1)ǫ
−
Xǫ
+
Y
− nX(nX − 1)nY + (nX + 1)nX(nX − 1)ǫ
+
Xǫ
−
Y
− nX(nX − 1)(nX − 2)]
}
P (nX , nY , t),
(3)
where we define step operators as
ǫ±XP (nX , nY , t) ≡ P (nX ± 1, nY , t),
ǫ±Y P (nX , nY , t) ≡ P (nX , nY ± 1, t).
(4)
The system reaches a nonequilibrium steady state with
a steady-state distribution written as P (nX , nY ). The
marginal distribution of nX that we evaluate in numerical
simulations is defined as P (nX) ≡
∑
nY
P (nX , nY )
From the master equation (3), we obtain the equations
for the time evolution of the densities
x ≡
∑
nX ,nY
nXP (nX , nY , t)/Ω,
y ≡
∑
nX ,nY
nY P (nX , nY , t)/Ω,
(5)
in the deterministic limit (Ω→∞), which read
dx
dt
= k1[A]− k−1x+ k3
(
x2y − x3
)
,
dy
dt
= k2[B]− k−2y − k3
(
x2y − x3
)
.
(6)
We have performed continuous time Monte Carlo sim-
ulations using the Gillespie algorithm46. We set the pa-
rameters to k1 = k2 = 0.1, k−1 = k3 = 1, [A] = 1,
[B] = 3. The rate k−2 is computed with ∆µ and the gen-
eralized detailed balance relation in Eq. (2), where ∆µ is
the control parameter. In Fig. 1, we show stochastic tra-
jectories of this model. For large enough∆µ, biochemical
oscillations set in.
2. Results
In the deterministic limit described by Eq. (6), for
∆µ ≥ ∆µc ≃ 3.95 the stationary solution becomes nu-
merically unstable and a limit cycle sets in. The ther-
modynamic flux associated with this force is the rate of
generation of the product A per volume Ω, which must
be equal the rate of consumption of B due to the conser-
vation of the number of particles in the reservoir. In the
deterministic limit this flux takes the form
J = k−1x− k1[A], (7)
where x is the stationary solution of Eq. (6). The rate
of entropy production is simply given by σ ≡ J∆µ in the
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FIG. 1. Trajectories of nX at different ∆µ in the Brusselator
with volume Ω = 105, the remaining parameters are given in
the main text.
steady state. As shown in Fig. 2(a), there is a disconti-
nuity in the first derivative ∂J/∂∆µ at the critical point
∆µc in this deterministic limit.
For a stochastic system, the average thermodynamic
flux reads
J = Ω−1k−1
∑
nX
nXP (nX)− k1[A]. (8)
In Fig. 2(a), we plot ∂J/∂∆µ as a function of ∆µ. With
increasing system size, the curve tends to the determinis-
tic result, with an increase of ∂J/∂∆µ close to the critical
point that gets steeper with increasing volume Ω.
For a finite system, there is a crossover to oscillatory
behaviors, as illustrated in Fig. 1. The stationary proba-
bility distribution P (nX) also changes at this crossover.
Below some finite-size critical point, where biochemical
oscillations do not take place, this distribution is uni-
modal, whereas above this critical point this distribution
becomes bimodal. This result is shown in Fig. 2(b). We
define the finite-size critical point ∆µc(Ω) as the mini-
mal ∆µ for which the distribution displays a local min-
imum. In Fig. 2(c), we show that ∆µc(Ω) converges to
∆µc ≃ 3.95, where the difference∆µc(Ω)−∆µc decreases
as a power-law with the system size Ω.
Fluctuations related to the thermodynamic flux can
be analyzed by considering a stochastic time-integrated
current Z, which is extensive in time. In a stochastic
trajectory, this random variable increases by one if an A
is produced, which happens if the transition with rate k−1
takes place, and it decreases by one if an A is consumed,
which happens if the transition with rate k1 takes place.
The average flux in (8) can be defined as
J ≡ 〈Z〉/(TΩ), (9)
where T is the time interval and the brackets denote an
average over stochastic trajectories. This time interval is
large enough compared to relaxation times so that the
stationary regime is probed. The diffusion coefficient
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FIG. 2. Phase transition in the Brusselator. (a) First deriva-
tive of the thermodynamic flux J as a function of ∆µ. The
critical point is ∆µc ≃ 3.95. (b) Stationary distribution of
chemical species X for Ω = 103 and different values of ∆µ.
(c) Difference between the point at which the distribution in
(b) becomes bimodal in a finite system ∆µc(Ω) and the crit-
ical point ∆µc ≃ 3.95 obtained with the deterministic rate
equations.
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FIG. 3. Diffusion coefficient for the Brusselator. (a) Diffusion
coefficient D as a function of ∆µ. (b) Maximum diffusion
coefficient Dc as a function of Ω.
(per volume) associated with Z is defined as
D ≡
〈Z2〉 − 〈Z〉2
2TΩ
. (10)
In Fig. 3(a) we show the diffusion coefficient D as a func-
tion of ∆µ. It has a maximum close to the critical point
that increases with the volume Ω. The maximum Dc as
a function of the volume Ω follows a power law with ef-
fective exponent 0.27± 0.02, as shown in Fig. 3(b). This
finite-size scaling indicates that D diverges at the critical
point.
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R X
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FIG. 4. Activator-inhibitor model. The transition rates for
the phosphorylation cycle of an enzyme M are represented
with black arrows. The completion of the counter clock-wise
cycle leads to the hydrolysis of one ATP, which liberates a
free energy ∆µ. Green arrows represent activation and the
red lines represent inhibition.
B. ACTIVATOR-INHIBITOR MODEL
1. Model definition
The activator-inhibitor model5 is a more elaborate bio-
chemical oscillator compared to the Brusselator. The
model is depicted in Fig. 4. It consists of activators R, in-
hibitors X , enzymes M and phosphatases K interacting
in a volume Ω. The external bath contains fixed concen-
trations of ATP, ADP, and Pi. The enzyme M can be
in four different states (M,MR,MpK, Mp), where Mp
is the phosphorylated form of the enzyme. For a phos-
phorylation reaction to take place, a R molecule must
be bound to the enzyme M and for a dephosphorylation
reaction to take place, a phosphatase K must be bound
to the enzyme M . In the phosphorylation reaction, one
ATP is transformed into an ADP, whereas in the de-
phosphorylation reaction a Pi is released in the solution.
In the anti-clockwise cycle shown in Fig. 4, one ATP is
transformed into ADP + Pi, hence the thermodynamic
5force associated with this cycle is
∆µ = µATP − µADP − µPi ≡ ln
a1a2f1f2
d1d2f−1f−2
, (11)
where the rates ai, di, f±i are given in Fig. 4.
Activators R and inhibitors X are related to this phos-
phorylation cycle in a feedback loop. The system con-
tains a fixed concentration of substrate S, which is con-
sumed (produced) when a R or X molecule is produced
(consumed). The phosphorylated form of the enzymeMp
catalyzes both the production of R with a rate k0 and
the production of X with a rate k3 (positive feedback).
Inhibitors X degrade R with a rate k2 (negative feed-
back) and can be spontaneously degraded with a rate k4.
For thermodynamic consistency, we must include reverse
rates, which are given by δi, where i = 0, ..., 4. These
reactions correspond to the lower part of Fig. 4 and can
be written as
Mp + S
k0−⇀↽−
δ0
Mp +R,
S
k1−⇀↽−
δ1
R,
X +R+ATP
k2−⇀↽−
δ2
X + S +ADP + Pi,
Mp + S
k3−⇀↽−
δ3
Mp +X,
X +ATP
k4−⇀↽−
δ4
S +ADP + Pi,
(12)
where generalized detailed balance45 requires
δ1 = k1δ0/k0,
δ2 = e
−∆µk2k0/δ0,
δ4 = e
−∆µk4k3/δ3.
(13)
In contrast to the model from5, we have added ATP con-
sumption in the chemical reactions Eq. (12) for thermo-
dynamic consistency.
An additional feature of the activator-inhibitor model
in relation to the Brusselator is the competition for a
scarce number of phosphatases nKtot . In order for oscil-
lations to set in, this number must be at some interme-
diate optimal value. If nKtot > nMtot , then the phospho-
rylation cycle shown in Fig. 4 for different enzymes does
not synchronize, since there is always free phosphatase to
bind to the enzyme, which is necessary for the dephos-
phorylation reaction. If nKtot is too small then only a
few enzymes can complete their cycle in a synchronized
way. This competition for a scarce resource is a common
feature in more realistic biochemical oscillators, such as
the model for KaiC oscillations in the next section.
The chemical master equation and the respective de-
terministic rate equations for this model are shown in
Appendix A. The state of the system is determined
by a vector of the numbers of molecules ni, with i =
R,X,K,M,MR,Mp,MpK. This vector is subjected to
the constraints nMtot = nM + nMR + nMp + nMpK and
nKtot = nK + nMpK , where nMtot is the total num-
ber of enzymes and nKtot is the total number of phos-
phatases. The volume of the system is Ω and concen-
trations are denoted by [i] ≡ ni/Ω. The concentra-
tion of enzymes is set to [Mtot] = 10, the concentra-
tion of phosphatases is [Ktot] = 0.8 and the concen-
tration of substrates is [S] = 1. The rates are set to
k0 = k2 = k3 = 0.02, k1 = 0.008, k4 = 0.01, δ0 = δ3 =
0.001, f1 = f2 = d1 = d2 = 0.3, a1 = a2 = 2. The rates
δ1, δ2, δ4 are computed with the generalized detailed bal-
ance relation in Eq. (13) and f−1 = f−2 = 2e
−∆µ/2,
where ∆µ is the control parameter.
The chemical species that we observe in our numerical
simulations is X , which, depending on ∆µ, can display
biochemical oscillations. The fluctuating thermodynamic
time-integrated current Z in this model is the total num-
ber of ATP consumed: if the reaction with rate f1 (f−1)
in Fig. 4 takes place, the Z increases (decreases) by one.
In addition, if the reactions with rate k2, k4 (δ2, δ4) in
Eq. (12) take place, Z also increases (decreases) by one.
The average flux J and diffusion coefficient per volume
D are defined as in Eq. (7) and Eq. (10), respectively.
2. Results
As shown in Fig. 5, the critical behavior of the
activator-inhibitor model is qualitatively similar to the
Brusselator. The first derivative of the flux ∂J/∂∆µ
has a discontinuity at the critical point in the thermo-
dynamic limit, as obtained from the deterministic rate
equations shown in Appendix A. Furthermore, the sta-
tionary distribution P (nX) becomes bimodal above the
critical point, which depends on the system size. The
diffusion coefficient D diverges at the critical point, as
shown in Fig. 6. The effective exponent related to the
finite-size scaling of the maximum diffusion coefficient Dc
is 0.46± 0.02, which is different from the one found in the
Brusselator.
C. KAIC MODEL
1. Model definition
There are several models for the oscillations of the
phosphorylation level of KaiC proteins (see47 for a sum-
mary). Here, we analyze a modified version of a model
introduced in40. In particular, we make all transitions
reversible for thermodynamic consistency.
The model contains KaiC molecules and KaiA
molecules in a volume Ω. Each KaiC molecule can
be in 14 different states denoted by Cj and C˜j , where
j = 0, 1, . . . , 6. The variables j indicates the phosphory-
lation level of the molecule, which has 6 phosphorylation
sites. The state Cj indicates the molecule is active and
the state C˜j indicates the molecule is inactive. The free
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FIG. 5. Phase transition for the activator-inhibitor model.
(a) First derivative of the flux ∂J/∂∆µ as a function of ∆µ.
The critical point is ∆µc ≃ 6.1. (b) Stationary probability
distribution of nX for different values of ∆µ and Ω = 100.
The distribution becomes bimodal above the critical point,
which is ∆µ ≃ 6.3 for this finite Ω. (c) Difference between
the point at which the distribution in (b) becomes bimodal
in a finite system ∆µc(Ω) and the critical point ∆µc ≃ 6.1
obtained with the deterministic rate equations.
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FIG. 6. Diffusion coefficient for the activator-inhibitor model.
(a) Diffusion coefficient D as a function of ∆µ. (b) Maximum
diffusion coefficient Dc as a function of Ω.
energy of state Cj minus the free energy of state C˜j is
given by
∆Ej = −E + jE/3. (14)
If the molecule is active then a phosphorylation reaction
can happen and if the molecule is inactive a dephospho-
rylation reaction can happen.
An essential feature of the model is that a KaiA
molecule must bind to the KaiC molecule for a phospho-
rylation reaction. The KaiA molecules play a role similar
to the phosphatases in the activator-inhibitor model, i.e.,
it is a scarce resource that synchronizes the phosphoryla-
tion cycle of different KaiC molecules. The dissociation
constant for the binding of an A to a KaiC molecule in
state Cj is Kj = K0a
j . The constant a > 1 makes the
dissociation constant an increasing function of j, which
is necessary for the onset of biochemical oscillations40.
The transition rates for the model are as follows.
KaiA(A) can bind with rate α to active states which are
partially phosphorylated (j = 0, ..., 5) to form a complex
ACj . The transition rate for the unbinding of A from a
7CT0
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.
C˜6
p0k
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k
(1 − p0)γ [A]p1γK
−1
0 e
E/6−∆µ/2
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−1
1 e
E/6−∆µ/2
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−1
4 e
E/6−∆µ/2
(1 − p5)γ γK−15 e
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FIG. 7. KaiC model with differential affinity. CTj = Cj+ACj
are the active KaiC states with j bound phosphates, which
can be bound to a KaiA(A). We assume fast binding and
unbinding of KaiA with Cj , which is characterized by a dis-
sociation constant Kj = K0a
j and the fraction of unbound
states pj = Kj/(Kj + [A]). Note that the fully phosphory-
lated state C6 cannot bind to A. C˜j are the inactive states
with j bound phosphates. The transition rate from Cj to
C˜j is ke
χE(j−3)/3 and the transition rate from C˜j to Cj is
keχ˜E(3−j)/3, where χ (χ˜) is an indicator function that is 0 (1)
for j = 0, 1, 2, 3 and 1(0) for j = 4, 5, 6. See Appendix B for
the chemical master equation and rate equations.
KaiC in state ACj is αKj . The rate for a phosphoryla-
tion reaction from ACj to Cj+1 is γ, while the rate for the
reverse reaction is rate γK−1j e
E/6−∆µ/2. Dephosphoryla-
tion from C˜j+1 to C˜j occurs with rate γ˜ , whereas the rate
for the reversed reaction is γ˜eE/6−∆µ/2. The transition
rate from Cj to C˜j is ke
χE(j−3)/3 and the transition rate
from C˜j to Cj is ke
(1−χ)E(3−j)/3, where χj is an indicator
function that is 0 for j = 0, 1, 2, 3 and 1 for j = 4, 5, 6.
This transition rates are thermodynamically consistent
since the affinity of a phosporylation cycle is ∆µ. The
chemical master equation for this model is shown in Ap-
pendix B.
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FIG. 8. Phase transition for the KaiC model. (a) First deriva-
tive of the flux ∂J/∂∆µ as a function of ∆µ. The critical
point is ∆µc ≃ 11.6. (b) Stationary probability distribu-
tion of the phosphorylation level nG for different values of
∆µ and Ω = 100. The distribution becomes bimodal above
the critical point, which is ∆µ ≃ 12.3 for this finite Ω. (c)
Difference between the point at which the distribution in (b)
becomes bimodal in a finite system ∆µc(Ω) and the critical
point ∆µc ≃ 11.6 obtained with the deterministic rate equa-
tions.
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FIG. 9. Diffusion coefficient for the KaiC model. (a) Diffusion
coefficient D as a function of ∆µ. (b) Maximum diffusion
coefficient Dc as a function of Ω.
We assume fast binding and unbinding kinetics of KaiA
and introduce coarse-grained states CTj = Cj + ACj for
j = 0, .., 5. The transition rates for this coarse-grained
model are shown in Fig. 7. Within this assumption of
timescale separation, the entropy production associated
with this coarse-grained model remains the same as the
entropy production of the full model48. The fraction of
unbound states among CTj is pj = Kj/(Kj + [A]), where
[A] is the concentration of free KaiA. This concentration
fulfills the constraint
[Atot] = [A] +
6∑
j=0
[A]
[
CTj
]
Kj + [A]
, (15)
where [Atot] Ω is the total number of KaiA molecules.
The total number of KaiC is [Ctot]Ω, which leads to the
constraint
[Ctot] =
6∑
j=0
(
[Cj ] + [C˜j ]
)
. (16)
The chemical master equation and deterministic rate
equations for this coarse-grained model are also shown
in Appendix B.
The concentration of KaiC is set to [Ctot] = 1, while
the concentration of KaiA is set to [Atot] = 0.04. The
parameters determining the transition rates are set to
γ = 10, γ˜ = 1, E = 20, k = e−E, a = 10,K0 = (1/3)10
−7.
The thermodynamic force∆µ is kept as a free parameter.
In our simulations, we monitor the phosphorylation level
of the KaiC system, which is defined as
nG =
6∑
j=1
j
(
[Cj ] + [C˜j ]
)
. (17)
Depending on ∆µ this quantity can exhibit oscillations.
The probability distribution P (nG) is the steady state
probability of this observable. The fluctuating thermody-
namic time-integrated current Z in this model is the to-
tal of number of ATP consumed. For the KaiC molecule
in the active state, if a transition that increases j takes
place Z increases by one and if the reversed transition
takes place Z decreases by one.
2. Results
The critical behavior of the present model is similar to
the critical behavior observed with the Brusselator and
the activator-inhibitor model, as shown in Fig. 8. The
first derivative of the flux ∂J/∂∆µ has a discontinuity at
the critical point in the thermodynamic limit and the sta-
tionary distribution P (nG) becomes bimodal above the
critical point. For this model, concerning the quantity
∂J/∂∆µ, we could not numerically access systems sizes
that are large enough for a better agreement between fi-
nite systems and the result from deterministic rate equa-
tions in Fig. 8(a). The diffusion coefficient D diverges at
the critical point, as shown in Fig. 9. The effective expo-
nent related to the finite-size scaling of the maximum Dc
as a function of the the volume Ω is 0.11± 0.01, which is
smaller then the effective exponents found for the other
two models.
III. CRITERIA FOR THE PRECISION OF
BIOCHEMICAL OSCILLATIONS
Biochemical oscillations can occur in finite systems
that display large fluctuations. In this section, we com-
pare two quantities that can quantify the precision of bio-
chemical oscillations, the number of coherent oscillations
and the Fano factor associated with the thermodynamic
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FIG. 10. Correlation function for species X (Eq. (18)) in the
Brusselator for different ∆µ. The volume is Ω = 103.
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FIG. 11. Comparison between the number of coherent oscil-
lations N and the Fano factor F . (a) Brusselator (N could
not be measured for Ω = 10). (b) Activator-inhibitor model.
(c) Model for KaiC oscillations. The right panels also show
the lower bound (20) for F
flux. The first quantity is related to the correlation func-
tion
CX(t) ≡
〈
(nX(t)− 〈nX〉) (nX(0)− 〈nX〉)
〉
. (18)
where nX(t) is the number of X molecules at time t, the
average number of molecules is 〈nX〉 ≡
∑
nX
nXP (nX).
Note that for the KaiC model the same expression is
valid with nG instead of nX . In our simulations of all
three models, the system starts at the initial time t = 0
in the stationary state. In Fig. 10, we show the corre-
lation function for species X in the Brusselator. Above
the critical point, it displays oscillations with an expo-
nentially decreasing amplitude . The number of coherent
oscillations N is defined as the decay time divided by
the period. It gives the typical number of oscillations for
which two different stochastic realizations would remain
coherent with each other. Therefore, a non-zero N is a
signature of biochemical oscillations, since it is a result of
a non-zero imaginary part of the first excited eigenvalue
of the stochastic matrix16,33.
As shown in Fig. 11, for a finite system, N becomes
non-zero above some critical value of ∆µ. It is difficult
to evaluate N numerically close to the critical point. If
the number of coherent oscillations is too small, it is not
possible to obtain the period of oscillation from direct
numerical evaluation of the correlation function. Hence,
with our numerical results, we cannot determine whether
N has a jump or approaches zero smoothly at the crit-
ical point. However, for simple three-state models it is
possible to evaluate N by calculating the first non-zero
eigenvalue of the stochastic matrix16,33. In this analytical
case, N approaches zero smoothly, without a discontinu-
ity. Within our numerical simulations, the first ∆µ for
which N becomes non-zero is smaller then the critical
∆µ for which the probability distribution of the oscillat-
ing species becomes bimodal, for all three models.
For the Brusselator, the scaling of N with the volume
Ω has been analyzed for both ∆µ close to the critical
point35,36 and ∆µ above the critical point34. In the first
case, the scaling N ∝ Ω1/2 has been observed, while in
the second N ∝ Ω1 has been obtained with the linear
noise approximation. We have observed that close to the
critical point our results for all three models, which are
shown in Fig. 11, agree with the scalingN ∝ Ω1/2. Above
the critical point, we find an exponent smaller than 1,
which suggest that the linear noise approximation, which
is valid for large Ω, does not apply to the system sizes
we have considered. Furthermore, in36 Xiao et al show
that N becomes non-zero below the critical point of the
Brusselator. We also observe a non-zero N below ∆µc
for the activator-inhibitor and KaiC models.
The Fano factor F associated with the fluctuating cur-
rent Z is defined as
F ≡
〈Z2〉 − 〈Z〉2
〈Z〉
=
2D
J
, (19)
which is a dimensionless parameter that quantifies the
fluctuations of the thermodynamic time-integrated cur-
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rent Z. A small Fano factor means that the current is
precise. In equilibrium, where there are no biochemi-
cal oscillations, the Fano factor diverges, since the av-
erage current is zero. Hence, this quantity is consistent
with the absence of biochemical oscillations in equilib-
rium. Due to the divergence of the diffusion coefficient
D, the Fano factor also diverges at the critical point in
the thermodynamic limit.
The thermodynamic uncertainty relation30 implies the
bound
F ≥
2
∆µ
. (20)
The highest precision achievable increases with the ther-
modynamic force ∆µ. Therefore, a large ∆µ is a neces-
sary condition for a small Fano factor. This inequality is
illustrated in Fig. 11. Close to the critical point, F is sub-
stantially larger than the bound with a local maximum
that increases with the volume Ω.
Two main motivations to consider the Fano factor as
a metric for the precision of biochemical oscillations are
as follow. First, in light of the thermodynamic uncer-
tainty relation, the Fano factor is a natural observable to
relate precision with thermodynamics. Second, for a sim-
ple unicyclic mode, the Fano factor can be related to the
cycle completion time (i.e. the period of oscillations)17.
Furthermore, the Fano factor associated with the ATP
consumption seems particularly appealing to quantifying
the precision of oscillations in the KaiC model, for which
we consider oscillations of the phosphorylation level.
However, our results in Fig. 11 indicate that F does
not appropriately quantify the precision of biochemical
oscillations. In particular, for the activator-inhibitor in
Fig. 11(b), the Fano factor is minimal below the critical
point where there are no biochemical oscillations. In gen-
eral, since the Fano factor diverges at the critical point in
the thermodynamic limit, a system that is large enough
should display a smaller F below the critical point as
compared to the F is some region above the critical point.
Note that it is more difficult to observe this effect in the
KaiC model, due to the smaller effective exponent asso-
ciated with the divergence of D. For the Brusselator and
KaiC model, above the crossover to oscillatory behavior,
an increase in∆µ leads to an increase inN and a decrease
in F . However, for the activator-inhibitor model, there
is a region around ∆µ ≃ 8 where both N and F increase
with ∆µ. Hence, for this last model, even if we restrict
to a region where biochemical oscillations exist, F does
not appropriately correlate with the precision quantified
by N .
IV. CONCLUSION
We have characterized a generic phase transition in
biochemical oscillators. A control parameter for this
phase transition is the thermodynamic force that drives
the system out of equilibrium. The stationary distribu-
tion of the oscillating chemical species becomes bimodal
above the critical force, the first derivative of the thermo-
dynamic flux with respect to the force is discontinuous
at criticality, the diffusion coefficient (and Fano factor)
associated with the thermodynamic flux diverges at crit-
icality, and the number of coherent oscillations, which is
a signature of biochemical oscillations, becomes nonzero
above the critical point. We have estimated effective ex-
ponents for the divergence of the diffusion coefficient with
a limited range of volumes, a more reliable calculation of
this exponent remains an open problem.
Three different models that display a limit cycle in the
deterministic limit have been investigated. We expect
that models for biochemical oscillators with this feature
display qualitatively the same critical behavior. For mod-
els with purely stochastic biochemical oscillations49, i.e.,
models that do not have a limit cycle in the determin-
istic limit, this phase transition remains unexplored so
far. The critical behavior of the entropy production has
also been investigated in several different models with
nonequilibrium phase transitions50–56. The present case
constitutes an example for which the first derivative of
entropy production, which is the flux multiplied by the
force, displays a discontinuity at the phase transition.
We expect that the diffusion coefficient associated with
the fluctuating entropy production diverges at the crit-
ical point for other models with nonequilibrium phase
transitions.
The precision of biochemical oscillations can be char-
acterized by the Fano factor F associated with the ther-
modynamic flux (or related first passage variables17) and
the number of coherent oscillations N . We have shown
that the Fano factor F can indicate high precision even
if there are no biochemical oscillations. This result sug-
gests that F does not quantify the precision of biochem-
ical oscillations in a reliable way. We anticipate that
this problem will also happen with probability currents
that are different from the thermodynamic flux, which
could be considered as more suitable for quantifying the
precision of biochemical oscillations, since their diffusion
coefficient will also diverge at criticality.
It remains to be seen whether and how the phase tran-
sition that we have characterized here can be used to
understand the operation and design principles of bio-
chemical oscillators. We have restricted our study to au-
tonomous biochemical oscillators. The theoretical inves-
tigation of biochemical oscillators under the influence of
an external periodic signal is an appealing direction for
future work.
Appendix A: Activator-inhibitor model
The time evolution of P (nR, nX , nK , nM, t), the prob-
ability to find the system in state (nR, nX , nK , nM) at
time t, is governed by the chemical master equation
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∂tP (nR, nX , nK , nM, t) =
{
k0[S]nMp(ǫ
−
R − 1) + Ωk1[S](ǫ
−
R − 1) + k3[S]nMp(ǫ
−
X − 1)
+ k2/Ω
[
nX(nR + 1)ǫ
+
R − nXnR
]
+ k4[(nX + 1)ǫ
+
X − nX ]
+ δ0/Ω
[
nMp(nR + 1)ǫ
+
R − nMpnR
]
+ δ1
[
(nR + 1)ǫ
+
R − nR
]
+ δ2
[
nX [S](ǫ
−
R − 1)
]
+ δ3/Ω
[
nMp(nX + 1)ǫ
+
X − nMpnX
]
+Ωδ4[S](ǫ
−
X − 1)
+ a1/Ω
[
(nM + 1)(nR − nMR + 1)ǫ
+
Mǫ
−
MR − (nR − nMR)nM
]
+ a2/Ω
[
(nK + 1)(nMp + 1)ǫ
+
Kǫ
+
Mp
ǫ−MpK − nMpnK
]
+ d1
[
(nMR + 1)ǫ
−
Mǫ
+
MR − nMR
]
+ d2
[
(nMpK + 1)ǫ
−
Kǫ
−
Mp
ǫ+MpK − nMpK
]
+ f1
[
(nMR + 1)ǫ
+
MRǫ
−
Mp
− nMR
]
+ f2
[
(nMpK + 1)ǫ
−
Kǫ
−
M ǫ
+
MpK
− nMpK
]
+ f−1/Ω
[
(nMp + 1)(nR − nMR + 1)ǫ
−
MRǫ
+
Mp
− (nR − nMR)nMp
]
+ f−2/Ω
[
(nK + 1)(nM + 1)ǫ
+
Kǫ
+
Mǫ
−
MpK
− nKnM
]}
P (nR, nX , nK , nM, t),
(A1)
where we define step operators as ǫ±i P (nR, nX , nK , nM, t) ≡ P (..., ni ± 1, ..., t) for i = R,X,K,M,MR,Mp,MpK.
From the master equation (A1), we obtain the equations for the time evolution of the concentrations in the deter-
ministic limit5, which reads
d[R]
dt
= k0[Mp][S] + k1[S]− k2[X ][R]− δ0[Mp][R]− δ1[R] + δ2[X ][S]
d[X ]
dt
= k3[Mp][S]− k4[X ]− δ3[Mp][X ] + δ4[S]
d[M ]
dt
= f2[MpK] + d1[MR]− a1[M ]([R]− [MR])− f−2[M ][K]
d[MR]
dt
= a1[M ]([R]− [MR]) + f−1[Mp]([R]− [MR])− (f1 + d1)[MR]
d[Mp]
dt
= f1[MR] + d2[MpK]− a2[Mp][K]− f−1[Mp]([R]− [MR])
d[MpK]
dt
= a2[Mp][K] + f−2[M ][K]− f2[MpK]− d2[MpK]
[Ktot] = [K] + [MpK].
(A2)
Note that [R] is the total concentration of activators and ([R] − [MR]) is the concentration of free activators which
can bind an enzyme M.
Appendix B: KaiC model
For the KaiCmodel, the state of the system is determined by the number of free active KaiC nC = (nC0 , nC1 , ..., nC6),
inactive KaiC n
C˜
= (nC˜0 , nC˜1 , ..., nC˜6), active KaiC bound with a KaiA nAC = (nAC0 , nAC1 , ..., nAC5) and free KaiA
nA. The time evolution of P (nC, nC˜, nAC, nA, t), the probability to find the system in state (nC, nC˜, nAC, nA, t) at
time t, is governed by the chemical master equation
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∂tP (nC, nC˜, nAC, nA, t) =
{ 5∑
j=0
γ
[
(nACj + 1)ǫ
+
ACj
ǫ−Cj+1 − nACj
]
+ γK−1j e
E/6−∆µ/2
[
(nCj+1 + 1)ǫ
+
Cj+1
ǫ−ACj − nCj+1
]
+
5∑
j=0
γ˜eE/6−∆µ/2
[
(nC˜j + 1)ǫ
+
C˜j
ǫ−
C˜j+1
− nC˜j
]
+ γ˜
[
(nC˜j+1 + 1)ǫ
+
C˜j+1
ǫ−
C˜j
− nC˜j+1
]
+
5∑
j=0
α/Ω
[
(nCj + 1)(nA + 1)ǫ
+
Cj
ǫ+Aǫ
−
ACj
− nCjnA
]
+ αKj
[
(nACj + 1)ǫ
+
ACj
ǫ−Cjǫ
−
A − nACj
]
+
6∑
j=0
keχE(3−j)/3
[
(nCj + 1)ǫ
+
Cj
ǫ−
C˜j
− nCj
]
+ keχ˜E(j−3)/3
[
(nC˜j + 1)ǫ
+
C˜j
ǫ−Cj − nC˜j
]
}
P (nC, nC˜, nAC, nA, t),
(B1)
where the step operators are defined as as ǫ±j P (nC, nC˜, nAC, nA, t) ≡ P (..., nj ± 1, ..., t) for j =
C0, ..., C6, C˜0, ..., C˜6, AC0, ..., AC5, A.
For the fast binding and unbinding kinetics of KaiA, we introduce coarse-grained active states nCT
j
= nCj + nACj ,
where j = 0, 5 and nCT
6
= nC6 (KaiA does not bind to C6). We define the unbound fraction of active states as
pj = Kj/(Kj + [A]). The concentration of free KaiA [A] is given implicitly by the constraint
[A] +
5∑
j=0
[A]
[
CTj
]
Kj + [A]
= [Atot] . (B2)
The state of the coarse-grained system is determined by the total number of active KaiC nCT = (nCT
1
, ..., nCT
6
) and
inactive KaiC n
C˜
= (nC˜1 , ..., nC˜6). The time evolution of P (nCT , nC˜, t), the probability to find the system in state
(nCT , nC˜, t) at time t, is governed by the following chemical master equation
∂tP (nC, nC˜, t) =
{ 5∑
j=0
(1− pj)γ
[
(nCT
j
+ 1)ǫ+n
CT
j
ǫ−n
CT
j+1
− nCT
j
]
+
4∑
j=0
[A]pjγK
−1
j e
E/6−∆µ/2
[
(nCT
j+1
+ 1)ǫ+n
CT
j+1
ǫ−n
CT
j
− nCT
j+1
]
+ γK−15 e
E/6−∆µ/2
[
(nCT
6
+ 1)ǫ+n
CT
6
ǫ−n
CT
5
− nCT
6
]
+
5∑
j=0
γ˜eE/6−∆µ/2
[
(nC˜j + 1)ǫ
+
C˜j
ǫ−
C˜j+1
− nC˜j
]
+ γ˜
[
(nC˜j+1 + 1)ǫ
+
C˜j+1
ǫ−
C˜j
− nC˜j+1
]
+
6∑
j=0
pjke
χE(3−j)/3
[
(nCj + 1)ǫ
+
Cj
ǫ−
C˜j
− nCj
]
+ keχ˜E(j−3)/3
[
(nC˜j + 1)ǫ
+
C˜j
ǫ−Cj − nC˜j
]
}
P (nC, nC˜, t).
(B3)
From the coarse-grained master equation (B3), we obtain the equations for the time evolution of the concentrations
in the deterministic limit
d
[
CTj
]
dt
= (1− pj−1)γ
[
CTj−1
]
+ pj+1γK
−1
j+1e
E/6−∆µ/2 [A]
[
CTj+1
]
− (1 − pj)γ
[
CTj
]
(1− δj,6)
− pjγK
−1
j e
E/6−∆µ/2 [A]
[
CTj
]
(1− δj,0) + ke
χ˜E(3−j)/3
[
C˜j
]
− pjke
χE(j−3)/3
[
CTj
]
d
[
C˜j
]
dt
= γ˜
([
C˜j+1
]
−
[
C˜j
]
(1− δj,0)
)
− γ˜e∆µ/2
([
C˜j−1
]
−
[
C˜j
]
(1− δj,6)
)
+ pjke
χE(j−3)/3 [Cj ]− ke
χ˜E(3−j)/3
[
C˜j
]
,
(B4)
13
where [A] is given by Eq. (B2).
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